It is a pharma private limited company based in Delhi, Delhi, India, established in 2005.
2005 | Delhi, Delhi, India | ActiveMakmaul Laboratories Private Limited, a active private limited company, was established on 31 August 2005 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U00304DL2005PTC140231. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹8.00 M and a paid-up capital of ₹6.00 M.
It upholds a compliant status. Its leadership includes Deepak Tayal (Director), Priyanka Agrawal (Director). Past directors included Lalit Kumar, Niti Aggarwal, Vipin Kumar Aggarwal. It holds ₹4.23 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 211 Sarja Marketmaharpur Sector 7 Rohini Delhi, Delhi, Delhi.
U00304DL2005PTC140231
140231
31 August 2005
₹8.00 M
₹6.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Makmaul Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepak Tayal | Director | 31 Aug 2005 | Current |
| Priyanka Agrawal | Director | 19 Jul 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Sep 2011 | Past |
| Pramod Abcsdd | Director | 23 Oct 2007 | Past |
| Pramod Abcsdd | Director | 23 Oct 2007 | Past |
| Pramod Abcsdd | Additional Director | 05 Dec 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Makmaul Laboratories Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 15.58% increase. The company also saw a slight decrease in profitability, with a 6.96% decrease in profit. The company's net worth moved up by a moderate rise of 1.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Makmaul Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹42,278,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Dec 2021 | Others | ₹2.35 M | Open |
| 10 Aug 2020 | Others | ₹4.60 M | Open |
| 06 Dec 2006 | Others | ₹3.53 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Makmaul Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Makmaul Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Makmaul Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Makmaul Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Makmaul Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
A charge with Others of Rs. 35.33 M registered on 06 Dec 2006 with Charge ID 10032882 was modified on 27 May 2022. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 2.35 M with Charge ID 100519604 was registered on 10 Dec 2021. was documented.
A charge with Others amounted to Rs. 4.60 M with Charge ID 100378644 was registered on 10 Aug 2020. was recorded as a recent event.
Priyanka Agrawal was appointed as a Director was appointed as a Director on 19 Jul 2014 & has been associated with this company since 11 years 4 months . was recorded as a recent event.
The CIN of Makmaul Laboratories Private Limited is U00304DL2005PTC140231.
Makmaul Laboratories Private Limited is headquartered at 211 Sarja Marketmaharpur Sector 7 Rohini Delhi, Delhi, Delhi.
Makmaul Laboratories Private Limited was incorporated on 31 August 2005.
The current directors of Makmaul Laboratories Private Limited are
The primary industry of Makmaul Laboratories Private Limited is Manufacturing.
Makmaul Laboratories Private Limited is unlisted.
The authorized capital of Makmaul Laboratories Private Limited is ₹8.00 M, and the paid-up capital is ₹6.00 M.
The compliance status of Makmaul Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX